These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 1380801

  • 1. Rapamycin inhibits the phosphorylation of p70 S6 kinase in IL-2 and mitogen-activated human T cells.
    Terada N, Lucas JJ, Szepesi A, Franklin RA, Takase K, Gelfand EW.
    Biochem Biophys Res Commun; 1992 Aug 14; 186(3):1315-21. PubMed ID: 1380801
    [Abstract] [Full Text] [Related]

  • 2. Failure of rapamycin to block proliferation once resting cells have entered the cell cycle despite inactivation of p70 S6 kinase.
    Terada N, Franklin RA, Lucas JJ, Blenis J, Gelfand EW.
    J Biol Chem; 1993 Jun 05; 268(16):12062-8. PubMed ID: 8389370
    [Abstract] [Full Text] [Related]

  • 3. Rapamycin-sensitive phosphorylation of ribosomal protein S17 by p70 S6 kinase.
    Patel HR, Terada N, Gelfand EW.
    Biochem Biophys Res Commun; 1996 Oct 14; 227(2):507-12. PubMed ID: 8878544
    [Abstract] [Full Text] [Related]

  • 4. Mechanism of action of the immunosuppressant rapamycin.
    Dumont FJ, Su Q.
    Life Sci; 1996 Oct 14; 58(5):373-95. PubMed ID: 8594303
    [Abstract] [Full Text] [Related]

  • 5. Interleukin 2 stimulation of p70 S6 kinase activity is inhibited by the immunosuppressant rapamycin.
    Calvo V, Crews CM, Vik TA, Bierer BE.
    Proc Natl Acad Sci U S A; 1992 Aug 15; 89(16):7571-5. PubMed ID: 1380162
    [Abstract] [Full Text] [Related]

  • 6. Rapamycin-induced inhibition of the 70-kilodalton S6 protein kinase.
    Price DJ, Grove JR, Calvo V, Avruch J, Bierer BE.
    Science; 1992 Aug 14; 257(5072):973-7. PubMed ID: 1380182
    [Abstract] [Full Text] [Related]

  • 7. Stimulation of receptor-associated kinase, tyrosine kinase, and MAP kinase is required for prolactin-mediated macromolecular biosynthesis and mitogenesis in Nb2 lymphoma.
    Carey GB, Liberti JP.
    Arch Biochem Biophys; 1995 Jan 10; 316(1):179-89. PubMed ID: 7840614
    [Abstract] [Full Text] [Related]

  • 8. Evidence that FK506 and rapamycin block T cell activation at different sites relative to early reversible phosphorylation involving the protein phosphatases PP1 and PP2A.
    Metcalfe S, Milner J.
    Transplantation; 1991 Jun 10; 51(6):1318-20. PubMed ID: 1710844
    [No Abstract] [Full Text] [Related]

  • 9. The insulin-induced signalling pathway leading to S6 and initiation factor 4E binding protein 1 phosphorylation bifurcates at a rapamycin-sensitive point immediately upstream of p70s6k.
    von Manteuffel SR, Dennis PB, Pullen N, Gingras AC, Sonenberg N, Thomas G.
    Mol Cell Biol; 1997 Sep 10; 17(9):5426-36. PubMed ID: 9271419
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Activation of 70-kDa S6 kinase, induced by the cytokines interleukin-3 and erythropoietin and inhibited by rapamycin, is not an absolute requirement for cell proliferation.
    Calvo V, Wood M, Gjertson C, Vik T, Bierer BE.
    Eur J Immunol; 1994 Nov 10; 24(11):2664-71. PubMed ID: 7957559
    [Abstract] [Full Text] [Related]

  • 13. Cross-linking CD28 leads to activation of 70-kDa S6 kinase.
    Pai SY, Calvo V, Wood M, Bierer BE.
    Eur J Immunol; 1994 Oct 10; 24(10):2364-8. PubMed ID: 7523138
    [Abstract] [Full Text] [Related]

  • 14. Differential effect of rapamycin and cyclosporin A in proliferation in a murine T cell line expressing either intermediate or high affinity receptor for IL-2.
    Rebollo A, Mérida I, Gómez J, Pitton C, Silva A, Martínez C, García A.
    Cytokine; 1995 Apr 10; 7(3):277-86. PubMed ID: 7543780
    [Abstract] [Full Text] [Related]

  • 15. Rapamycin selectively inhibits interleukin-2 activation of p70 S6 kinase.
    Kuo CJ, Chung J, Fiorentino DF, Flanagan WM, Blenis J, Crabtree GR.
    Nature; 1992 Jul 02; 358(6381):70-3. PubMed ID: 1614535
    [Abstract] [Full Text] [Related]

  • 16. Interleukin-2 receptor (CD25) upregulation on human T-lymphocytes: sensitivity to immunosuppressants is defined by the mode of T-lymphocyte activation.
    Ryffel B, Willcocks JL, Brooks N, Woerly G.
    Immunopharmacology; 1995 Sep 02; 30(3):199-207. PubMed ID: 8557519
    [Abstract] [Full Text] [Related]

  • 17. Inhibition of p70/p85 S6 kinase activities in T cells by dexamethasone.
    Monfar M, Blenis J.
    Mol Endocrinol; 1996 Sep 02; 10(9):1107-15. PubMed ID: 8885245
    [Abstract] [Full Text] [Related]

  • 18. Transforming growth factor beta 1 inhibits interleukin-1-induced but enhances ionomycin-induced interferon-gamma production in a T cell lymphoma: comparison with the effects of rapamycin.
    Dumont FJ, Kastner CA.
    J Cell Physiol; 1994 Jul 02; 160(1):141-53. PubMed ID: 8021294
    [Abstract] [Full Text] [Related]

  • 19. Rapamycin inhibition of interleukin-2-dependent p33cdk2 and p34cdc2 kinase activation in T lymphocytes.
    Morice WG, Wiederrecht G, Brunn GJ, Siekierka JJ, Abraham RT.
    J Biol Chem; 1993 Oct 25; 268(30):22737-45. PubMed ID: 8226784
    [Abstract] [Full Text] [Related]

  • 20. Translational regulation during activation of porcine peripheral blood lymphocytes: association and phosphorylation of the alpha and gamma subunits of the initiation factor complex eIF-4F.
    Morley SJ, Pain VM.
    Biochem J; 1995 Dec 01; 312 ( Pt 2)(Pt 2):627-35. PubMed ID: 8526879
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.